Sphingomyelin-based nanosystems (SNs) for the development of anticancer miRNA therapeutics

1. Nagachinta, S.
2. Bouzo, B.L.
3. Vazquez-Rios, A.J.
4. Lopez, R.
5. de la Fuente, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/PHARMACEUTICS12020189 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus